SL
Schedule 13D filing
SINO LION VENTURES Ltd disclosed a 25.3% stake in INDP
SINO LION VENTURES Ltd reported owning 25.3% of Indaptus Therapeutics, Inc. (INDP) (38,895,000 shares) in a Schedule 13D filed Oct 22, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 22, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.